KTTA- Pasithea Therapeutics Corp.

Name: Pasithea Therapeutics Corp. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Pasithea Therapeutics Corp. (KTTA) has 6 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. KTTA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Steinman Lawrence	199.7K	$156.8K	-
CEO	Marques Tiago	73.3K	$57.6K	-
Dir	Novak Alfred J	42.9K	$33.7K	-
Dir	Dumesnil Simon	35.8K	$28.1K	-
Dir	Leahy Emer	33.3K	$26.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 28, 2025	Steinman Lawrence64	Director	Buy	133,333	$0.75	$99,999.75	+200.9%	-43.3%	-
Nov 28, 2025	Marques Tiago	Chief Executive Officer	Buy	33,333	$0.75	$24,999.75	+83.3%	-43.3%	-
Nov 28, 2025	Dumesnil Simon	Director	Buy	33,333	$0.75	$24,999.75	+1,333%	-43.3%	-
May 12, 2025	Marques Tiago	Chief Executive Officer	Sell	960	$0.83	$792.00	-2.3%	-22.0%	-8.6%
Jun 2, 2023	Steinman Lawrence64	Director	Buy	30,000	$0.43	$12,930.00	+2.3%	+51.4%	-31.8%
Oct 17, 2022	Delaney David	Member Of 10% Owner Group	Buy	1,000	$1.11	$1,110.00	+0.4%	-35.1%	-59.4%
Sep 29, 2022	Shahinian Eric	Member Of 10% Owner Group	Buy	64,357	$1.19	$76,299.04	+1.8%	-51.3%	-59.3%
Sep 6, 2022	Shahinian Eric	Member Of 10% Owner Group	Buy	88,901	$1.13	$100,366.68	+1.8%	-14.0%	-45.6%
Aug 30, 2022	Shahinian Eric	Member Of 10% Owner Group	Buy	22,828	$1.15	$26,292.78	+0.7%	-14.5%	-47.8%
Aug 19, 2022	Geller Avi	Member Of 10% Owner Group	Buy	54,644	$1.30	$70,938.84	New	-21.3%	-55.4%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC